Real-world characteristics and treatment patterns of transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, bortezomib, lenalidomide, and dexamethasone (DVRd) as front-line treatment: Results from a multicenter chart review study Meeting Abstract
| Authors: | Tan, C. R.; Gordan, L.; Dileo, R.; Mewawalla, P.; Larson, S. M.; Davies, F. E.; Oveisi, D.; Gupta-Werner, N.; Medhekar, R.; Cortoos, A.; Armoon, M.; Rahman, A.; Eynde, C. V.; Lafeuille, M. H.; Reitan, J.; Milkovitch, G.; Bubalo, J.; Forman, A.; Sborov, D. W.; Kaila, S.; Usmani, S. Z. |
| Abstract Title: | Real-world characteristics and treatment patterns of transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, bortezomib, lenalidomide, and dexamethasone (DVRd) as front-line treatment: Results from a multicenter chart review study |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 3760 |
| Language: | English |
| ACCESSION: | WOS:001413016800028 |
| DOI: | 10.1182/blood-2024-201712 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work